Arrayit Corporation Receives Purchase Order for Proprietary Microarray Substrates

Arrayit Corporation Receives Purchase Order for Proprietary Microarray Substrates 

Arrayit Corporation (OTC: ARYC), a developer, manufacturer and marketer of proprietary life science technologies and consumables for disease prevention, treatment and cure, announces the receipt of a $228,000 purchase order from an Asia-based life sciences company. The purchase order is for ARYC’s proprietary microarray substrates, which serve as building blocks for printed microarrays used in genomic research and molecular diagnostics. The company expects the purchase order to have a positive impact on its sales and earnings in the third and fourth quarter of 2013. 

To read more about ARYC and subscribe to a monthly update, CEO interview etc, please click here – http://www.listonstreetpulse.com/tag/ARYC/

About Arrayit Corporation                            

Arrayit Corporation is a Sunnyvale, California-based company leading and empowering the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development, and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. The company’s innovative products and services help scientists and clinicians explore the human genome as well as the genomes of plants and animals. Arrayit’s products are used by every major research center in the world.

About Liston Street Pulse                                                 

Liston Street Pulse is a leading provider of financial research. The company has significant expertise in U.S. listed small cap and micro-cap stocks. Over the years, Liston Street Pulse’s original and unbiased analysis has helped the investor community immensely.